Huons Global Co., Ltd. Logo

Huons Global Co., Ltd.

Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.

084110 | KO

Overview

Corporate Details

ISIN(s):
KR7084110006
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 9층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Global Co., Ltd. is a holding company for a total healthcare group focused on providing solutions for human health. The company's core business encompasses the research, development, manufacturing, and sale of pharmaceutical products, medical devices, cosmetics, and health-functional food components. With a history dating back to 1965, the group has notable achievements, including the development of local anesthetics. Huons Global prioritizes expanding its research and development capabilities to find new growth engines and is actively advancing its presence in the global healthcare market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정(자회사의 주요경영사항)
Korean 6.3 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정(자회사의 주요경영사항) (중간배당)
Korean 9.6 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-07 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 14.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.7 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 10.5 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.8 MB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출(자회사의 주요경영사항)
Korean 26.8 KB
2025-03-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all Huons Global Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Huons Global Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Huons Global Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.